Inhibition by boswellic acids of human leukocyte elastase

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 1, 1997, Pages 460-463

  Safayhi, Hasan ^a   Rall, Beatrice ^a   Sailer, Eckart Roderich ^a   Ammon, Hermann P T ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 ETHYL 6 [[3 FLUORO 5 (3,4,5,6 TETRAHYDRO 4 METHOXY 2H PYRAN 4 YL)]PHENOXYMETHYL] 2 QUINOLONE; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 6 [[3 FLUORO 5 (3,4,5,6 TETRAHYDRO 4 METHOXY 2H PYRAN 4 YL)]PHENOXYMETHYL] 1 METHYL 2 QUINOLONE; ACETYL 11 OXO BETA BOSWELLIC ACID; ARACHIDONATE 5 LIPOXYGENASE; BOSWELLIC ACID; CHYMOTRYPSIN; GLYCYRRHETINIC ACID; GLYCYRRHETINIC ACID DERIVATIVE; HYDROCORTISONE; LEUKOCYTE ELASTASE; LIPOXYGENASE INHIBITOR; NORDIHYDROGUAIARETIC ACID; TESTOSTERONE; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG; URSOLIC ACID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; INHIBITION KINETICS; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONATE 5-LIPOXYGENASE; HUMANS; LEUKOCYTE ELASTASE; STRUCTURE-ACTIVITY RELATIONSHIP; TRITERPENES;

EID: 0030973083     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. 4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata. Planta Med. 57: 203-207, 1991.
2. ASHE, B. M. AND ZIMMERMAN, M.: Specific inhibition of human granulocyte elastase by cis-unsaturated fatty acids and activation by the corresponding alcohols. Biochem. Biophys. Res. Commun. 75: 194-199, 1977.
3. BERNSTEIN, P. R., EDWARDS, P. D. AND WILLIAMS, J. C.: Inhibitors of human leukocyte elastase. In Progress in Medicinal Chemistry 37 ed. by G. P. Ellis, and D. K. Luscombe, pp. 59-120, Elsevier, Amsterdam, 1994.
4. BIETH, J., SPIESS, B. AND WERMUTH, C. G.: The synthesis and analytical use of a highly sensitive and convenient substrate of elastase. Biochem. Med. 11: 350-357, 1974.
5. BISSWANGER, H.: Theorie und Methoden der Enzymkinetik. Verlag Chemie, Weinheim, 1979.
6. CHEN, X. S., SHELLER, J. R., JOHNSON, E. N. AND FUNK, C. D.: Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature (Lond.) 372: 179-182, 1994.
7. COOK, L. AND TERNAI, B.: Similar binding sites for unsaturated fatty acids and alkyl 2-pyrone inhibitors of human sputum elastase. Biol. Chem. Hoppe-Seyler 369: 627-631, 1988.
8. DELMAR, E. G., LARGMAN, C., BRODRICK, J. W. AND GEOKAS, M. C.: A sensitive new substrate for chymotrypsin. Anal. Biochem. 99: 316-320, 1979.
9. HELDT, R. M., WINKING, M. AND SIMMET, T.: Cysteinyl-leukotrienes as potential mediators of the peritumoral brain oedema in astrocytoma patients (Abstract). Naunyn-Schmiedebergs Arch. Pharmacol. 353 4S: R142-538, 1996.
10. HORNEBECK, W., MOCZAR, E., SZECSI, J. AND ROBERT, L.: Fatty acid peptide derivatives as model compounds to protect elastin against degradation by elastases. Biochem. Pharmacol. 34: 3315-3321, 1985.
11. MARTINETZ, D., LOHS, K. AND JANZEN, J.: Weihrauch und Myrrhe: Kulturge-schichtliche und wirtschaftl. Bedeutung; Botanik, Chemie, Medizin. Wiss. Verl.-Ges., Stuttgart, 1988.
12. MAYATEPEK, E. AND HOFFMANN, G. F.: Leukotrienes: Biosynthesis, metabolism, and pathophysiologic significance. Pediatr. Res. 37: 1-9, 1995.
13. REDDY, G. K., DHAR, S. C. AND SINGH, G. B.: Urinary excretion of connective tissue metabolites under the influence of a new non-steroidal antiinflammatory agent in adjuvant induced arthritis. Agents Actions 22: 99-105, 1987.
14. SAFAYHI, H., MACK, T. AND AMMON, H. P. T.: Protection by boswellic acids against galactosamine/endotoxin-induced hepatitis in mice. Biochem. Pharmacol. 41: 1536-1537, 1991.
15. SAFAYHI, H., MACK, T., SABIERAJ, J., ANAZODO, M. I., SUBRAMANIAN, L. R. AND AMMON, H. P. T.: Boswellic acids: Novel, specific, nonredox inhibitors of 5-lipoxygenase. J. Pharmacol. Exp. Ther. 261: 1143-1146, 1992.
16. SAFAYHI, H., SAILER, E.-R. AND AMMON, H. P. T.: Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-β-boswellic acid. Mol. Pharmacol. 47: 1212-1216, 1995.
17. SAILER, E.-R., HOERNLEIN, R. F., SUBRAMANIAN, L. R., AMMON, H. P. T. AND SAFAYHI, H.: Preparation of novel analogues of the nonredox-type. noncompetitive leukotriene biosynthesis inhibitor AKBA. Archiv. Pharm. 329: 54-56, 1996b.
18. SAILER, E.-R., SUBRAMANIAN, L. R., RALL, B., HOERNLEIN, R. F., AMMON, H. P. T. AND SAFAYHI, H.: Acetyl-11-keto-β-boswellic acid (AKBA): Structure requirements for binding and 5-lipoxygenase inhibitory activity. Br. J. Pharmacol. 117: 615-618, 1996a.
19. SAUER, A., AIGNER, J., HARTUNG, T., MINUTH, W. AND WENDEL, A.: Granulocyte mediated hepatotoxicity after endotoxin stimulation depends on adhesion and elastase release. Naunyn-Schmiedeberg's Arch. Pharmacol. 351S: A495, 1995.
20. SCHADE, U. F., ENGEL, R. AND JAKOBS, D.: Differential protective activities of site specific lipoxygenase inhibitors in endotoxic shock and production of tumor necrosis factor. Int. J. Immunopharmacol. 13: 565-571, 1991.
21. SCHADE, U. F., ENGEL, R. AND JAKOBS, D.: Lipoxygenase inhibitors but not site specific 5-lipoxygenase blockers protect against endotoxic shock and inhibit production of tumor necrosis factor. Eicosanoids 5S: S45-S47, 1992.
22. SINGH, G. B. AND ATAL, C. K.: Pharmacology of an extract of salai guggal ex-Boswellia serrato, a new non-steroidal anti-inflammatory agent. Agents Actions 18: 407-412, 1986.
23. TYAGI, S. C. AND SIMON, S. R.: Inhibitors directed to binding domains in neutrophil elastase. Biochemistry 29: 9970-9977, 1990.
24. YING, Q.-L., RINEHART, A. R., SIMON, S. R. AND CHERONIS, J. C.: Inhibition of human leucocyte elastase by ursolic acid. Biochem. J. 277: 521-526, 1991.